arrow
M

Makoto Endo

kyushu university
H指数:47
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical presentation and treatment strategies of proximal femoral fibrous dysplasia without deformity

股骨近端纤维结构不良无畸形患者的临床表现与治疗策略

2026-10-200
OAAI
Preoperative administration of denosumab is a feasible adjuvant option for the treatment of resectable giant cell tumor of bone in the spine: A multi-institutional study by the Japanese Musculoskeletal Oncology group

术前使用地诺单抗是治疗脊柱可切除骨巨细胞瘤的可行辅助治疗选择:日本骨肌肉肿瘤学组的多机构研究

2026-05-010
PRE
Cholesterol-metabolic tumor-associated macrophages regulate tumor budding-like cell subpopulation to promote chordoma stemness via BACH1/ANGPTL4/SDC4 axis

胆固醇代谢的肿瘤相关巨噬细胞通过BACH1/ANGPTL4/SDC4轴调控肿瘤出芽样细胞亚群以促进脊索瘤的干细胞特性

2025-12-140
PRE
Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907)

阿特朱单抗在晚期肺泡软组织肉瘤中的临床、免疫学及基因组学发现:一项II期试验(ALBERT试验/NCCH1907)

2025-11-110
PRE
Empowering pediatric, adolescent, and young adult patients with cancer utilizing generative AI chatbots to reduce psychological burden and enhance treatment engagement: a pilot study
2025-02-250
OAAI
Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines for the use of G-CSF 2022

剂量密集化疗在预防性使用培非格司亭的情况下对早期乳腺癌的疗效与安全性:一项基于《2022年G-CSF使用临床实践指南》的系统评价与荟萃分析

2025-02-120
PRE
Risk Factors for Locoregional Relapse After Segmentectomy: Supplementary Analysis of the JCOG0802/WJOG4607L Trial

段切除术后的局部区域复发的危险因素:JCOG0802/WJOG4607L试验的补充分析

2025-02-016
PRE
Impact of COVID-19 pandemic on bone and soft tissue sarcoma patients' consultation and diagnosis

新型冠状病毒肺炎大流行对骨与软组织肉瘤患者会诊和诊断的影响

2024-09-040
OAAI
Phase I trial of NY-ESO-1 TCR-T cell therapy combined with nanoparticulate vaccine but without lymphodepletion for STS
2023-11-010
OAAI